Your session is about to expire
← Back to Search
Gait Retraining for Knee Osteoarthritis
N/A
Waitlist Available
Led By Michael A Hunt, PT, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
report knee pain greater than or equal to 3/10 on a numerical pain rating scale (0-10) during most days of the previous month
TFOA of Grade 2 (mild) or 3 (moderate) on the Kellgren and Lawrence scale
Must not have
non-English speaking
cardiovascular or cardiopulmonary disease preventing from safely performing moderate intensity running
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will study the effects of a 4-week running gait retraining program on symptoms and running biomechanics in runners with Tibiofemoral osteoarthritis (TFOA).
Who is the study for?
This trial is for adult runners who have mild to moderate knee osteoarthritis, run at least 10 km weekly for over six months, can comfortably run on a treadmill for 30 minutes, and experience knee pain most days. It's not suitable for non-English speakers, those with recent serious knee injuries or certain medications, heart conditions that make running unsafe, or other leg issues affecting running.
What is being tested?
The study tests a 4-week program designed to change how people with knee osteoarthritis run (gait retraining). The goal is to see if these changes can reduce their symptoms like pain and improve their ability to function without putting too much stress on the knees.
What are the potential side effects?
Since this isn't a drug trial but an exercise-based intervention focusing on changing running style, side effects may include muscle soreness or fatigue due to new gait patterns. However, significant adverse effects are unlikely.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have experienced knee pain of at least 3 out of 10 nearly every day last month.
Select...
My arthritis is mild to moderate according to the Kellgren and Lawrence scale.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not speak English.
Select...
I have heart or lung conditions that prevent me from safely doing moderate running.
Select...
I have a condition in my lower limb that affects my ability to run, not including TFOA.
Select...
I have had a serious knee injury in the past.
Select...
I have a neurological or inflammatory arthritis condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 weeks, 4 weeks, 2 months, 3 months, 4 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Knee
Peak knee adduction moment impulse change
Secondary study objectives
Numerical pain rating scale for pain during running change
Peak knee flexion moment impulse change
Step rate change
Other study objectives
Compliance with gait retraining change
Numeric pain rating scale for usual pain change
Numeric pain rating scale for worst pain change
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Gait retrainingExperimental Treatment1 Intervention
Runners will be taught how to modify their running gait through multiple laboratory sessions and in-field training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gait retraining
2011
Completed Phase 2
~150
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,481 Previous Clinical Trials
2,494,898 Total Patients Enrolled
26 Trials studying Osteoarthritis
1,950 Patients Enrolled for Osteoarthritis
Michael A Hunt, PT, PhDPrincipal InvestigatorUniversity of British Columbia
3 Previous Clinical Trials
199 Total Patients Enrolled
3 Trials studying Osteoarthritis
199 Patients Enrolled for Osteoarthritis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I haven't used any corticosteroids or viscosupplementation in the last 6 months.I do not speak English.I have experienced knee pain of at least 3 out of 10 nearly every day last month.I have heart or lung conditions that prevent me from safely doing moderate running.I have a condition in my lower limb that affects my ability to run, not including TFOA.My arthritis is mild to moderate according to the Kellgren and Lawrence scale.You have been consistently running for at least 6 months, covering a distance of 10 kilometers every week.I have had a serious knee injury in the past.I have a neurological or inflammatory arthritis condition.You must be able to run on a treadmill for at least 30 minutes without discomfort.I regularly use pain relievers or knee braces for running.
Research Study Groups:
This trial has the following groups:- Group 1: Gait retraining
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Osteoarthritis Patient Testimony for trial: Trial Name: NCT03314428 — N/A